Neuropsychiatric symptoms and the outcome of cognitive trajectories in older adults free of dementia: The Mayo Clinic Study of Aging.


Journal

International journal of geriatric psychiatry
ISSN: 1099-1166
Titre abrégé: Int J Geriatr Psychiatry
Pays: England
ID NLM: 8710629

Informations de publication

Date de publication:
09 2021
Historique:
revised: 11 02 2021
received: 25 11 2020
accepted: 26 02 2021
pubmed: 17 3 2021
medline: 12 8 2021
entrez: 16 3 2021
Statut: ppublish

Résumé

Neuropsychiatric symptoms (NPS) are associated with the risk of incident mild cognitive impairment (MCI) and dementia. We examined associations between NPS and the outcomes of global and domain-specific cognitive trajectories. In this longitudinal study conducted in the setting of the population-based Mayo Clinic Study of Aging, 5081 community-dwelling, nondemented individuals aged ≥50 years (51% males) underwent NPS assessment using Neuropsychiatric Inventory Questionnaire (NPI-Q), and Beck Depression and Anxiety Inventories (BDI-II, BAI). Global and domain-specific (memory, language, attention, and visuospatial skills) cognitive performance was assessed through neuropsychological testing every 15 months. Associations between baseline NPS and trajectories for individual yearly change in cognitive z-scores were calculated using linear mixed-effect models. Cognition declined regardless of NPS status over the median follow-up of 4.5 years. Presence of NPS was associated with increased cognitive decline. Differences in annualized change in global cognition z-scores for participants with NPS compared to without NPS ranged from -0.018 (95% CI -0.032, -0.004; p = 0.011) for irritability to -0.159 (-0.254, -0.065; p = 0.001) for hallucinations. Associations between NPS and annual decline in global cognition were significant for most NPI-Q-assessed NPS and clinical depression (BDI-II≥13). Participants with NPI-Q-assessed depression, apathy, nighttime behavior, and clinical depression had greater decline in all domain-specific z-scores; presence of delusions and anxiety was associated with more pronounced decline in language, attention and visuospatial skills. NPS were associated with a more accelerated cognitive decline. Clinical assessment and potential treatment of NPS is warranted even in a community setting as NPS may impact cognitive decline in nondemented individuals.

Identifiants

pubmed: 33724517
doi: 10.1002/gps.5528
pmc: PMC8451750
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1362-1369

Subventions

Organisme : NIMH NIH HHS
ID : K01 MH068351
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG034676
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG016574
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG057708
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG006786
Pays : United States

Informations de copyright

© 2021 The Authors. International Journal of Geriatric Psychiatry published by John Wiley & Sons Ltd.

Références

Am J Geriatr Psychiatry. 2013 Jul;21(7):685-95
pubmed: 23567400
J Intern Med. 2004 Sep;256(3):183-94
pubmed: 15324362
Aging Ment Health. 2008 Jul;12(4):517-23
pubmed: 18791901
Am J Geriatr Psychiatry. 2012 Mar;20(3):266-75
pubmed: 22354117
Alzheimers Dement. 2013 Sep;9(5):602-8
pubmed: 23562430
J Clin Psychiatry. 2018 Sep 4;79(5):
pubmed: 30192448
Am J Geriatr Psychiatry. 2020 Jan;28(1):64-71
pubmed: 31186157
Am J Psychiatry. 2014 May;171(5):572-81
pubmed: 24700290
Psychol Med. 2019 Oct;49(13):2168-2176
pubmed: 30370877
Am J Geriatr Psychiatry. 2019 Aug;27(8):823-834
pubmed: 30902566
Int J Geriatr Psychiatry. 2021 Sep;36(9):1362-1369
pubmed: 33724517
Am J Geriatr Psychiatry. 2019 Jan;27(1):42-52
pubmed: 30409551
J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):233-9
pubmed: 11001602
Arch Neurol. 2006 Mar;63(3):435-40
pubmed: 16533972
Neurology. 2002 Aug 13;59(3):364-70
pubmed: 12177369
Int Psychogeriatr. 2017 Jul;29(7):1137-1145
pubmed: 28390447
Aging (Milano). 2001 Jun;13(3):240-6
pubmed: 11444257
Am J Geriatr Psychiatry. 2016 Oct;24(10):823-42
pubmed: 27591161
J Clin Exp Neuropsychol. 1998 Apr;20(2):194-200
pubmed: 9777473
Aging Ment Health. 2018 Apr;22(4):474-482
pubmed: 28071922
Neurology. 2015 Mar 3;84(9):935-43
pubmed: 25653291
Am J Geriatr Psychiatry. 2013 Feb;21(2):119-28
pubmed: 23343485
Neuroepidemiology. 2008;30(1):58-69
pubmed: 18259084
Am J Geriatr Psychiatry. 2005 Jun;13(6):460-8
pubmed: 15956265
Br J Psychiatry. 2002 Nov;181:406-10
pubmed: 12411266
JAMA. 2002 Sep 25;288(12):1475-83
pubmed: 12243634
Am J Geriatr Psychiatry. 2016 Feb;24(2):117-25
pubmed: 26209222
Am J Geriatr Psychiatry. 2005 May;13(5):402-8
pubmed: 15879589
Neurology. 2007 Jun 12;68(24):2085-92
pubmed: 17562829
J Alzheimers Dis. 2012;31(2):411-20
pubmed: 22571979
Dement Geriatr Cogn Disord. 2008;25(2):115-26
pubmed: 18087152
J Intern Med. 2004 Sep;256(3):240-6
pubmed: 15324367
Psychol Med. 2010 Jul;40(7):1193-201
pubmed: 19903364
J Alzheimers Dis. 2010;20(1):175-83
pubmed: 20164594
Arch Gen Psychiatry. 2008 Oct;65(10):1193-8
pubmed: 18838636

Auteurs

Janina Krell-Roesch (J)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
Institute of Sports and Sports Science, Karlsruhe Institute of Technology, Karlsruhe, Germany.

Jeremy A Syrjanen (JA)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.

Mary M Machulda (MM)

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.

Teresa J Christianson (TJ)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.

Walter K Kremers (WK)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.

Michelle M Mielke (MM)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

David S Knopman (DS)

Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

Ronald C Petersen (RC)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

Maria Vassilaki (M)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.

Yonas E Geda (YE)

Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH